Management of essential hypertension

Bibliography

• JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION AND TREATMENT OF HIGH BLOOD PRESSURE: The sixth report of the Joint National Committee on Prevention, Detection, Evalua-tion and Treatment of High Blood Pressure. Arch. Intern. Med. (1997) 157:2413–2446.
   PubMed Web of Science ®Google Scholar
• ••A major national guideline for the treatment ofhypertension.
   Google Scholar
• MARQUES-VIDAL P, TUOMILEHTO J: Hypertensionawareness, treatment and control in the community: is the 'rule of halves' still valid? J. Human Hypertens. (1997) 11:213–220.
   PubMed Web of Science ®Google Scholar
• COLHOUN HM, DONG W, POULTER NR: Blood pressurescreening, management and control in England: results from the health survey from England 1994. J. Hypertens. (1998) 16:747–752.
   PubMed Web of Science ®Google Scholar
• BRITISH HYPERTENSION SOCIETY: Managementguidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br. Med. J. (1993) 306:983–987.
   PubMedGoogle Scholar
• WHO-ISH HYPERTENSION GUIDELINES COMMITTEE: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J. Hypertens. (1999) 17:151–185.
   PubMed Web of Science ®Google Scholar
• ••An international guideline for the treatment of hypertension.
   Google Scholar
• CRUIKSHANK JM, THORP JM, ZACHARIAS FJ: Benefitsand potential harm of lowering high blood pressure. Lancet (1987) 1:581–583.
   PubMed Web of Science ®Google Scholar
• SAMUELSSON 0, WILHELMSEN L, ANDERSSON OK,PENNERT K, BERGLUND G: Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Goteborg, Sweden. J. Am. Med. Assn. (1987) 258:1768–1776.
   Google Scholar
• HANSSON L, ZANCHETTI A, CARRUTHERS SG et al.:Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet (1998) 351:1755–1762.
   PubMed Web of Science ®Google Scholar
• •A major reference upon which goals for hypertension are based.
   Google Scholar
• KAPLAN NM: The deadly quartet. Upper body obesity,glucose intolerance, hypertriglyceridemia and hypertension. Arch. Intern. Med. (1989) 149:1514–1520.
   PubMed Web of Science ®Google Scholar
• TRIALS OF HYPERTENSION PREVENTION COLLABORA-TIVE RESEARCH GROUP: Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hyperten-sion Prevention, Phase II. Arch. Intern. Med. (1997) 157:657–667.
   PubMedGoogle Scholar
• WHELTON PK, APPEL LJ, ESPELAND MA et al: Sodiumreduction and weight loss in the treatment of hypertension in older persons. A randomized trial of nonpharmacologic interventions in the elderly (TONE). J. Am. Med. Assn. (1998) 279:839–846.
   Google Scholar
• APPEL LI MOORE TJ, OBARZANEK E et al: A clinical trialof the effects of dietary patterns on blood pressure. New Engl. J. Med. (1997) 336:1117–1124.
   PubMedGoogle Scholar
• REID CM, DART AM, DWAR EM, JENNINGS GL: Interac-tions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects. J. Hypertens. (1994) 12:291–301.
   PubMed Web of Science ®Google Scholar
• JENNINGS GLR: Exercise and blood pressure: walk, run or swim? J. Hypertens. (1997) 15:567–569.
   Google Scholar
• LAW MR: Epidemiological evidence on salt and blood pressure. Am. J. Hypertens. (1997) 10:42S–45S.
   Google Scholar
• CUTLER JA, FOLLMAN D, ALEXANDER PS: Randomizedcontrolled trials of sodium reduction: an overview. Am. J. Clin. Nutr. (1997) 65(Suppl.):6435–6515.
   Google Scholar
• MIDGELY JP, MATTHEW AG, GREENWOOD CMT, LOGAN AG: Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. J. Am. Med. Assn. (1996) 275:1590–1597.
   PubMedGoogle Scholar
• WEINBERGER MH: Salt sensitivity of blood pressure in humans. Hypertension (1996) 27 (Part 2):481–490.
   Google Scholar
• ALDERMAN MH, COHEN H, MADHAVAN S: Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES D. Lancet (1998) 351:781–785.
   PubMed Web of Science ®Google Scholar
• PUDDEY IB, BEILIN LJ, VANDONGEN R: Alcohol, hypertension and the cardiovascular system: a critical appraisal. Addiction Biol. (1997) 2:159–170.
   PubMed Web of Science ®Google Scholar
• STAMLER J, CAGGIULA AW, GRANDITS GA: Chapter 12. Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am. J. Clin. Nutr. (1997) 65(Suppl.):338S–365S.
   Google Scholar
• DICKERSON JEC, HINGORANI AD, ASHBY MJ, PALMER CR, BROWN MJ: Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet (1999) 353:2008–2013.
   PubMedGoogle Scholar
• SHEP CO-OPERATIVE RESEARCH GROUP: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Med. Assn. (1991) 265:3255–3264.
   PubMed Web of Science ®Google Scholar
• •One of the first large-scale studies of hypertension in the elderly.
   Google Scholar
• MESSERLI FH, GROSSMAN E, GOLDBOURT U: Are 8-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. J. Am. Merl. Assn. (1998) 279:1903–1907.
   PubMed Web of Science ®Google Scholar
• UK PROSPECTIVE DIABETES STUDY GROUP: Efficacy of atenolol and captopril in reducing risk of macrovas-cular and microvascular complications in Type 2 diabetes: UKPDS 39. Br. Med. J. (1998) 317:713–720.
   PubMed Web of Science ®Google Scholar
• ••This trial proved the many benefits of hypertension controlin diabetics.
   Google Scholar
• RYAN TJ, ANDERSON JL, BRANIFF BA et al.: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J. Am. Coll. Cardiol. (1996) 28:1328–1428.
   PubMed Web of Science ®Google Scholar
• PSATY BM, HECKBERT SR, KOEPSELL TD eta].: The risk of myocardial infarction associated with antihyperten-sive drug therapies. J. Am. Med. Assn. (1995) 274:620–625.
   Google Scholar
• STAESSEN JA, FAGARD R, THUS L et al.: Randomised double blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet (1997) 350:757–764.
   PubMed Web of Science ®Google Scholar
• ROSEI EA, DAL PALU C, LEONETTI G, MAGNANI B, PRESSINA A, ZANCHETTI A: Clinical results of the Verapamil in Hypertension and Atherosclerosis Study. Hypertens. (1997) 15:1337–1344.
   Google Scholar
• HANSSON L, LINDHOLM LH, NISKANEN L et al.: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet (1999) 353:611–616.
   PubMed Web of Science ®Google Scholar
• NATIONAL HIGH BLOOD PRESSURE EDUCATION PROGRAM WORKING GROUP ON HIGH BLOOD PRESSURE IN PREGNANCY: National High Blood Pressure Education Program working group report on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. (1990) 163:1689–1712.
   Google Scholar
• NWACHUKU CE, CUTLER JA: The explosion of morbidity and mortality trials in hypertension. Corr. Opin. Nephrol Hypertens. (1997) 6:230–236.
   PubMed Web of Science ®Google Scholar